These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32908454)

  • 1. Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.
    Hu G; Sun N; Jiang J; Chen X
    Cancer Cell Int; 2020; 20():433. PubMed ID: 32908454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
    Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
    Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
    Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
    Front Oncol; 2021; 11():799223. PubMed ID: 35096599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
    Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
    World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
    Zeng Z; Xie D; Gong J
    PeerJ; 2020; 8():e9624. PubMed ID: 32821544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer.
    Liu D; Xu Y; Fang Y; Hu K
    Front Genet; 2022; 13():885553. PubMed ID: 35692814
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer.
    Zhang T; Yu S; Zhao S
    J Gastrointest Oncol; 2022 Feb; 13(1):84-101. PubMed ID: 35284118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer.
    Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C
    Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer.
    Hu M; Chong R; Liu W; Liu S; Liu X
    Front Oncol; 2023; 13():1155418. PubMed ID: 37197421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of fatty acid metabolism-related genes in patients with gastric cancer.
    Xu W; Ding H; Zhang M; Liu L; Yin M; Weng Z; Xu C
    Transl Cancer Res; 2022 Oct; 11(10):3593-3609. PubMed ID: 36388036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic model based on regulatory T-cell-related genes in gastric cancer: Systematic construction and validation.
    Tong Q; Ling Y
    Int J Exp Pathol; 2023 Oct; 104(5):226-236. PubMed ID: 37350375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and Analysis of an Individualized Immune-Related Gene Signature for the Prognosis of Gastric Cancer.
    Li M; Cao W; Huang B; Zhu Z; Chen Y; Zhang J; Cao G; Chen B
    Front Surg; 2022; 9():829237. PubMed ID: 35174205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
    Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
    J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.